Web NewDrugInformation.com

Cormax Drug - Cormax The trade name of the product as shown on the labeling. Dosage - CREAM; TOPICAL The product dosage form and route separated by a semi-colon. Active Ingredient(s) - Clobetasol Propionate Multiple ingredients are in alphabetical order. Strength - 0.05% The potency of the active ingredient(s), Clobetasol Propionate. May repeat for multiple part products. Applicant - HEALTHPOINT The firm name holding legal responsibility for Cormax. The firm name is condensed to a maximum twenty character unique string. New Drug Application (NDA) Number - 074220 The FDA assigned number to Cormax. Format is nnnnnn. Product Number - 001 The FDA assigned number to identify Cormax. Each strength is a separate product. May repeat for multiple part products. Format is nnn. Therapeutic Equivalence (TE) Code - AB1 The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products. Approval Date - May 16, 1997 The date Cormax was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982". Reference Listed Drug (RLD) - No The pioneer or innovator of Cormax. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No. Type - RX The group or category of approved drugs Cormax is in. Format is RX, OTC, DISCN. Applicant Full Name - Healthpoint Ltd The full name of the firm holding legal responsibility for the new application of Cormax. Cormax Clobetasol Propionate 0.05% Cream; Topical Clobetasol Propionate 0.05% Cream; Topical Clobetasol Propionate 0.05% Cream; Topical Clobetasol Propionate 0.05% Cream; Topical Clobetasol Propionate 0.05% Cream; Topical Clobetasol Propionate 0.05% Cream; Topical Clobetasol Propionate (emollient) 0.05% Cream; Topical Clobetasol Propionate (emollient) 0.05% Cream; Topical Cormax 0.05% Cream; Topical Olux 0.05% Aerosol, Foam; Topical NewDrugInformation